NEKTAR THERAPEUTICS (NKTR) Stock Analyst Earnings Estimates
NASDAQ:NKTR - Nasdaq - US6402681083 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 92.1M -9.62% | 90.122M -2.15% | 98.427M 9.22% | 43.959M -55.34% | 40.725M -7.36% | 34.91M -14.28% | 43.557M 24.77% | 93.289M 114.18% | 185.7M 99.06% | 315.63M 69.97% | 488.86M 54.88% | |
| EBITDA YoY % growth | -227.3M 47.38% | -127.41M 43.95% | -125.527M 1.48% | -147.158M -17.23% | -170.402M -15.80% | -194.82M -14.33% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -240.3M 46.13% | -135.225M 43.73% | -129.918M 3.92% | -162.459M -25.05% | -189.032M -16.36% | -255.619M -35.23% | -318.516M -24.61% | -315.849M 0.84% | -93.755M 70.32% | 25.788M 127.51% | 228.59M 786.42% | |
| Operating Margin | -260.91% | -150.05% | -131.99% | -369.57% | -464.17% | -732.22% | -731.26% | -338.57% | -50.49% | 8.17% | 46.76% | |
| EPS YoY % growth | -29.55 30.88% | -15.75 46.70% | -11.70 25.71% | -11.94 -2.04% | -19.72 -65.21% | -14.12 28.41% | -9.64 31.74% | -0.46 95.24% | N/A | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -3.10 17.45% | -2.90 -7.52% | -2.84 -18.36% | -2.77 23.00% | -3.14 -1.32% | -3.06 -5.40% | -3.10 -9.07% | -3.06 -10.40% | -3.06 2.44% | -3.06 | -3.21 -3.70% |
| Revenue Q2Q % growth | 11.066M -52.89% | 11.175M -53.68% | 11.024M -62.21% | 10.988M 5.19% | 11.526M 4.16% | 11.529M 3.17% | 11.536M 4.64% | 13.26M 20.68% | 13.26M 15.04% | 13.26M 15.01% | 13.26M 14.94% |
| EBITDA Q2Q % growth | -35.7M -6.83% | -31.62M -4.56% | -31.62M -55.83% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -39.333M -7.81% | -38.831M -13.21% | -37.732M -52.87% | -40.648M 8.38% | -42.563M -8.21% | -44.608M -14.88% | -46.795M -24.02% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -3.60 -26.32% | -2.51 | -1.09 | -43.22% |
| Q4 2024 Q2Q % growth | -2.40 27.27% | -2.57 | 0.17 | 6.77% |
| Q3 2024 Q2Q % growth | -2.70 25.00% | -3.23 | 0.53 | 16.31% |
| Q2 2024 Q2Q % growth | -3.75 7.41% | -3.12 | -0.63 | -20.38% |
| Q1 2024 Q2Q % growth | -2.85 40.62% | -2.91 | 0.06 | 1.96% |
| Q4 2023 Q2Q % growth | -3.30 31.25% | -3.25 | -0.05 | -1.55% |
| Q3 2023 Q2Q % growth | -3.60 22.58% | -3.05 | -0.55 | -17.98% |
| Q2 2023 Q2Q % growth | -4.05 68.24% | -4.34 | 0.29 | 6.75% |
| Q1 2023 Q2Q % growth | -4.80 34.69% | -3.86 | -0.94 | -24.21% |
| Q4 2022 Q2Q % growth | -4.80 59.49% | -6.92 | 2.12 | 30.65% |
| Q3 2022 Q2Q % growth | -4.65 55.71% | -6.88 | 2.23 | 32.39% |
| Q2 2022 Q2Q % growth | -12.75 -23.19% | -14.32 | 1.57 | 10.99% |
| Q1 2022 Q2Q % growth | -7.35 26.87% | -10.36 | 3.01 | 29.07% |
| Q4 2021 Q2Q % growth | -11.85 -21.54% | -12.38 | 0.53 | 4.31% |
| Q3 2021 Q2Q % growth | -10.50 -14.75% | -12.21 | 1.71 | 14.04% |
| Q2 2021 Q2Q % growth | -10.35 -53.33% | -11.18 | 0.83 | 7.44% |
| Q1 2021 Q2Q % growth | -10.05 -26.42% | -11.05 | 1.00 | 9.02% |
| Q4 2020 Q2Q % growth | -9.75 -1.56% | -10.40 | 0.65 | 6.27% |
| Q3 2020 Q2Q % growth | -9.15 -8.93% | -11.32 | 2.17 | 19.14% |
| Q2 2020 Q2Q % growth | -6.75 28.57% | -10.47 | 3.72 | 35.53% |
| Q1 2020 Q2Q % growth | -7.95 22.06% | -11.80 | 3.85 | 32.63% |
| Q4 2019 Q2Q % growth | -9.60 | -10.42 | 0.82 | 7.83% |
| Q3 2019 Q2Q % growth | -8.40 | -11.11 | 2.71 | 24.43% |
| Q2 2019 Q2Q % growth | -9.45 | -12.19 | 2.74 | 22.50% |
| Q1 2019 Q2Q % growth | -10.20 | -10.53 | 0.33 | 3.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 10.446M -51.73% | 15.664M | -5.218M | -33.31% |
| Q4 2024 Q2Q % growth | 29.175M 22.15% | 30.457M | -1.282M | -4.21% |
| Q3 2024 Q2Q % growth | 24.124M -0.08% | 18.646M | 5.478M | 29.38% |
| Q2 2024 Q2Q % growth | 23.489M 14.59% | 17.896M | 5.593M | 31.25% |
| Q1 2024 Q2Q % growth | 21.639M 0.21% | 15.649M | 5.99M | 38.28% |
| Q4 2023 Q2Q % growth | 23.885M 8.57% | 18.416M | 5.469M | 29.70% |
| Q3 2023 Q2Q % growth | 24.144M 2.31% | 21.739M | 2.405M | 11.06% |
| Q2 2023 Q2Q % growth | 20.499M -5.10% | 22.263M | -1.764M | -7.92% |
| Q1 2023 Q2Q % growth | 21.594M -12.93% | 20.235M | 1.359M | 6.72% |
| Q4 2022 Q2Q % growth | 22M -12.00% | 22.576M | -576K | -2.55% |
| Q3 2022 Q2Q % growth | 23.6M -5.22% | 23.061M | 539K | 2.34% |
| Q2 2022 Q2Q % growth | 21.6M -23.67% | 23.118M | -1.518M | -6.57% |
| Q1 2022 Q2Q % growth | 24.8M 5.08% | 24.865M | -65K | -0.26% |
| Q4 2021 Q2Q % growth | 25M 6.38% | 25.84M | -840K | -3.25% |
| Q3 2021 Q2Q % growth | 24.9M -17.00% | 28.425M | -3.525M | -12.40% |
| Q2 2021 Q2Q % growth | 28.3M -42.01% | 26.5M | 1.8M | 6.79% |
| Q1 2021 Q2Q % growth | 23.6M -53.36% | 27.442M | -3.842M | -14.00% |
| Q4 2020 Q2Q % growth | 23.5M -30.68% | 30.615M | -7.115M | -23.24% |
| Q3 2020 Q2Q % growth | 30M 2.74% | 26.859M | 3.141M | 11.69% |
| Q2 2020 Q2Q % growth | 48.8M 109.44% | 23.255M | 25.545M | 109.85% |
| Q1 2020 Q2Q % growth | 50.6M 79.43% | 48.595M | 2.005M | 4.13% |
| Q4 2019 Q2Q % growth | 33.9M | 27.468M | 6.432M | 23.42% |
| Q3 2019 Q2Q % growth | 29.2M | 26.924M | 2.276M | 8.45% |
| Q2 2019 Q2Q % growth | 23.3M | 27.186M | -3.886M | -14.29% |
| Q1 2019 Q2Q % growth | 28.2M | 28.188M | 12K | 0.04% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3.76% | -1763.56% | 5.59% | -1672.81% |
| Revenue | 0.05% | -40.77% | 0.16% | -40.94% |